HIGHLIGHTS
- who: Lin Tang from the Advanced Innovation Center for Soft Matter Science and Engineering, University of Chemical Technology, Department of Pathology, Peking University International Hospital, China have published the research work: Advances in Nanotechnology-Based Immunotherapy for Glioblastoma, in the Journal: (JOURNAL) of 16/05/2022
- what: In the process of tumorigenesis and development, immune checkpoints have become one of the main reasons for immune tolerance.
- how: Results showed that the number of regulatory T_cells (Treg) (CD4+CD3+Foxp3+) decreased the immunosuppressive tumor microenvironment was relieved and immune T_cells induced antitumor immunity was . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.